Enhanced leiomyoma organ culture: optimized tissue handling and ready-to-use scaffold
Abstract
Uterine leiomyomas, or fibroids, are the most common benign tumors in women, yet their pathophysiology remains poorly understood because reliable culture models are lacking. Unlike 2D culture, fibroid organ culture preserves driver mutations in smooth muscle cells while maintaining the tumor’s structural integrity, cell interactions, and heterogeneity. This study introduces an enhanced fibroid organ culture that builds on our previous model. Fresh tumor tissues were manually sectioned, placed on commercial scaffolds, and cultured under controlled conditions. Replacing the vibratome with manual slicing made tissue preparation faster and feasible across all fibroid types. Highly porous commercial scaffolds may facilitate nutrient and oxygen exchange, supporting cell viability and reducing apoptosis. This improved model supports broader adoption of fibroid organ culture using commercially available scaffolds, offering a more accessible platform for mechanistic studies and the development of targeted therapeutic strategies.
Related
- Development of mechanically optimized biomimetic hybrid scaffold–stem cell constructs for functional tendon regeneration and restoration of mechanical integrity
- Artificial Intelligence‐Optimized Image Biomarker Identification for Sinonasal Inverted Papilloma Diagnosis Using Image‐Enhanced Versus White‐Light Endoscopy
- Brain tumor segmentation using a combination of graph cut and optimized U-Net with genetic algorithm: An efficient hybrid framework for enhanced medical image analysis
- Optimized renewable dual-biopolymer hydraulic fracturing fluid with zirconium crosslinker for enhanced thermal stability
- An optimized product-enhanced reverse transcriptase assay for sensitive and quantitative detection of HIV viral load and phenotypic drug resistance
BibTeX
@article{vazquez2026enhanced,
title = {{Enhanced leiomyoma organ culture: optimized tissue handling and ready-to-use scaffold}},
author = {Paula Vázquez and Silvia Beltrán-Flores and Francisco Montes de Oca and Araceli Delgado and Teresa A. Almeida},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-73971-0},
url = {https://www.nature.com/articles/s41598-026-73971-0},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Enhanced leiomyoma organ culture: optimized tissue handling and ready-to-use scaffold
AU - Paula Vázquez
AU - Silvia Beltrán-Flores
AU - Francisco Montes de Oca
AU - Araceli Delgado
AU - Teresa A. Almeida
PY - 2026
DA - 2026/10/02
JO - Scientific Reports
DO - 10.1038/s41598-026-73971-0
UR - https://www.nature.com/articles/s41598-026-73971-0
AB - Uterine leiomyomas, or fibroids, are the most common benign tumors in women, yet their pathophysiology remains poorly understood because reliable culture models are lacking. Unlike 2D culture, fibroid organ culture preserves driver mutations in smooth muscle cells while maintaining the tumor’s structural integrity, cell interactions, and heterogeneity. This study introduces an enhanced fibroid organ culture that builds on our previous model. Fresh tumor tissues were manually sectioned, placed on commercial scaffolds, and cultured under controlled conditions. Replacing the vibratome with manual slicing made tissue preparation faster and feasible across all fibroid types. Highly porous commercial scaffolds may facilitate nutrient and oxygen exchange, supporting cell viability and reducing apoptosis. This improved model supports broader adoption of fibroid organ culture using commercially available scaffolds, offering a more accessible platform for mechanistic studies and the development of targeted therapeutic strategies.
SN - 2045-2322
ER -